• Mr. Kashif Hussain
• Mr. Praveen Kumar Ashok
• Sunil Dhanola

Amylmetacresol is an antiseptic used to treat infections of the mouth and throat. 2,4-Dichlorobenzyl alcohol is a mild antiseptic with a broad spectrum for bacterial and virus associated with mouth and throat infections. As per ISO 17025, Validation is the documentary proof that the particular requirements for a specific intended use are fulfilled. This research aimed to study concurrent process validation for Amylmetacresol and 2,4-Dichlorobenzyl alcohol 2.5gm lozenges. The critical parameter involved in manufacturing stages were identified and evaluated as per the validation master plan. The outcome indicated that this process validation data provides a high degree of assurance that the manufacturing process produces products meeting its predetermined specifications and quality attributes.

PHARMACEUTICAL CONCURRENT PROCESS VALIDATION

"PHARMACEUTICAL CONCURRENT PROCESS VALIDATION OF AMYLMETACRESOL AND 2, 4-DICHLORO BENZYL ALCOHOL LOZENGES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 8, page no.c97-c115, August-2022, Available :http://www.jetir.org/papers/JETIR2208211.pdf

"PHARMACEUTICAL CONCURRENT PROCESS VALIDATION OF AMYLMETACRESOL AND 2, 4-DICHLORO BENZYL ALCOHOL LOZENGES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 8, page no. ppc97-c115, August-2022, Available at : http://www.jetir.org/papers/JETIR2208211.pdf